Par Drugs (India) Price on November 13, 2024
| PAR Stock | 288.35 4.15 1.42% |
Below is the normalized historical share price chart for Par Drugs And extending back to May 30, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Par Drugs stands at 288.35, as last reported on the 27th of November, with the highest price reaching 294.85 and the lowest price hitting 285.30 during the day.
If you're considering investing in Par Stock, it is important to understand the factors that can impact its price. Par Drugs appears to be very steady, given 3 months investment horizon. Par Drugs And maintains Sharpe Ratio (i.e., Efficiency) of 0.0647, which implies the firm had a 0.0647% return per unit of risk over the last 3 months. We have found thirty technical indicators for Par Drugs And, which you can use to evaluate the volatility of the company. Please evaluate Par Drugs' Semi Deviation of 2.06, coefficient of variation of 1069.03, and Risk Adjusted Performance of 0.0796 to confirm if our risk estimates are consistent with your expectations.
As of November 27, 2024, Total Stockholder Equity is expected to decline to about 483.9 M. In addition to that, Common Stock Shares Outstanding is expected to decline to about 11.2 M. Par Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 242.7506 | 50 Day MA 260.6474 | Beta 0.153 |
Par |
Sharpe Ratio = 0.0647
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PAR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.0 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 5 95% of assets perform better |
Based on monthly moving average Par Drugs is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Par Drugs by adding it to a well-diversified portfolio.
Price Book 3.6668 | Book Value 78.685 | Enterprise Value 3.4 B | Enterprise Value Ebitda 11.9454 | Price Sales 3.4024 |
Related Headline
KNR Constructions Headline on 13th of November 2024
KNR Constructions Ltd sees 13.3 percent surge in stock price... by news.google.com
KNR Constructions Ltd sees 13.3 percent surge in stock price, outperforms sector and Sensex MarketsMojo
Par Drugs Valuation on November 13, 2024
It is possible to determine the worth of Par Drugs on a given historical date. On November 13, 2024 Par was worth 268.15 at the beginning of the trading date compared to the closed value of 269.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Par Drugs stock. Still, in general, we apply an absolute valuation method to find Par Drugs' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Par Drugs where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Par Drugs' related companies.
| Open | High | Low | Close | Volume | |
| 293.70 | 293.70 | 271.05 | 273.55 | 90,054 | |
11/13/2024 | 268.15 | 277.75 | 268.05 | 269.00 | 66,012 |
| 270.10 | 278.00 | 270.10 | 271.10 | 58,016 |
| Backtest Par Drugs | | | Par Drugs History | | | Par Drugs Valuation | Previous | Next |
Par Drugs Trading Date Momentum on November 13, 2024
| On November 14 2024 Par Drugs And was traded for 271.10 at the closing time. The highest price during the trading period was 278.00 and the lowest recorded bid was listed for 270.10 . The volume for the day was 58 K. This history from November 14, 2024 contributed to the next trading day price growth. The trading delta at closing time to the next closing price was 0.78% . The trading delta at closing time to the current price is 11.15% . |
Par Drugs And Fundamentals Correlations and Trends
By evaluating Par Drugs' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Par Drugs' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Par financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Par Drugs Stock history
Par Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Par is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Par Drugs And will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Par Drugs stock prices may prove useful in developing a viable investing in Par Drugs
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.2 M | 11.2 M | |
| Net Income Applicable To Common Shares | 106 M | 65.2 M |
Par Drugs Quarterly Net Working Capital |
|
Par Drugs Stock Technical Analysis
Par Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Par Drugs Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Par Drugs And cannot be verified against its exchange. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Par Drugs November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Par Drugs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Par Drugs shares will generate the highest return on investment. By undertsting and applying Par Drugs stock market strength indicators, traders can identify Par Drugs And entry and exit signals to maximize returns
Par Drugs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Par Drugs' price direction in advance. Along with the technical and fundamental analysis of Par Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Par to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0796 | |||
| Jensen Alpha | 0.3675 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.104 | |||
| Treynor Ratio | (15.86) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Par Stock analysis
When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |